Freebies to cost Sanofi $109 million

Share this article:

Sanofi will pay up to $109 million to settle allegations that it gave healthcare providers free units of its knee injection drug Hyalgan to induce them to prescribe the drug, according to the Department of Justice. The settlement also resolves claims that the company submitted false average sales price reports for Hyalgan that omitted the free units distributed.


Share this article:

More in Products

FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

PDI introduces new swab

PDI introduces new swab

PDI has debuted the PrevanticsĀ® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to ...

Oregon Freeze Dry releases Easy Meal

Oregon Freeze Dry releases Easy Meal

A new brand from Oregon Freeze Dry is designed to help long-term care and other healthcare facilities prepare for a disaster.